These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 11786111)

  • 21. The inhibitor cytokine interleukin-1 receptor antagonist synergistically augments cyclosporine immunosuppression in a rat cardiac allograft model.
    Shiraishi M; Csete M; Yasunaga C; McDiarmid SV; Vannice JL; Busuttil RW; Shaked A
    J Surg Res; 1995 May; 58(5):465-70. PubMed ID: 7745957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment with an HLA-peptide and cyclosporine A prolongs rat small bowel allograft survival.
    Willetts IE; Tam PK; Morris PJ; Dallman MJ
    J Pediatr Surg; 1997 Mar; 32(3):469-72. PubMed ID: 9094020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of intimal hyperplasia in rat aortic allografts with cyclosporine.
    Stoltenberg RL; Geraghty J; Steele DM; Kennedy E; Hullett DA; Sollinger HW
    Transplantation; 1995 Nov; 60(9):993-8. PubMed ID: 7491707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunobiology and long-term graft function in a transplant heterotopic renal rat model.
    Maluf DG; Fisher RA; Riley R; Wallace M; Tawes J; Bu D; Posner M
    Clin Transplant; 2002; 16 Suppl 7():6-14. PubMed ID: 12372038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of sphingosine-1-phosphate 1 receptor agonist, KRP-203, in combination with a subtherapeutic dose of cyclosporine A for rat renal transplantation.
    Fujishiro J; Kudou S; Iwai S; Takahashi M; Hakamata Y; Kinoshita M; Iwanami S; Izawa S; Yasue T; Hashizume K; Murakami T; Kobayashi E
    Transplantation; 2006 Sep; 82(6):804-12. PubMed ID: 17006328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined donor leucocyte administration and immunosuppressive drug treatment for survival of rat heart allografts.
    den Dulk M; Wang C; Li J; Clark DA; Hibberd AD; Terpstra OT; McCaughan GW; Bishop GA
    Transpl Immunol; 2004 Nov; 13(3):177-84. PubMed ID: 15381200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapamycin and cyclosporine have different effects on expression of Ang-1 and Ang-2 and Tie2 in rat renal allograft with chronic allograft nephropathy.
    Ma X; Lu YP; Yang L; Song J; Luo GH; Shi YJ; Li YP
    Transplant Proc; 2008 Oct; 40(8):2804-7. PubMed ID: 18929866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Piceatannol in combination with low doses of cyclosporine A prolongs kidney allograft survival in a stringent rat transplantation model.
    Fernandez LA; Torrealba J; Yagci G; Ishido N; Tsuchida M; Tae Kim H; Dong Y; Oberley T; Fechner J; Colburn MJ; Schultz J; Kanmaz T; Hu H; Knechtle SJ; Hamawy MM
    Transplantation; 2002 Dec; 74(11):1609-17. PubMed ID: 12490796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel immunomodulator KRP-203 combined with cyclosporine prolonged graft survival and abrogated transplant vasculopathy in rat heart allografts.
    Takahashi M; Shimizu H; Murakami T; Enosawa S; Suzuki C; Takeno Y; Hakamata Y; Kudou S; Izawa S; Yasue T; Kobayashi E
    Transplant Proc; 2005; 37(1):143-5. PubMed ID: 15808575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rejection following donor or recipient preoperative treatment with FTY720 in rat small bowel transplantation.
    Sakagawa T; Kiyochi H; Honda K; Kobayashi N
    Transpl Immunol; 2004 Nov; 13(3):161-8. PubMed ID: 15381198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Oleanolic acid synergizes with cyclosporine A to prolong renal allograft survival in rats].
    Qian K; Liao W; Li J; Jiang H; Zhou H; Long J; Qin G; Wang Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jun; 34(6):843-6. PubMed ID: 24968842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination therapy with cyclosporine and interleukin-4 or interleukin-10 prolongs survival of synergeneic pancreatic islet grafts in nonobese diabetic mice: islet graft survival does not correlate with mRNA levels of type 1 or type 2 cytokines, or transforming growth factor-beta in the islet grafts.
    Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Rajotte RV; Power RF
    Transplantation; 1997 Dec; 64(11):1525-31. PubMed ID: 9415551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of ultraviolet-B-irradiated donor-specific blood transfusions and peritransplant immunosuppression with cyclosporine on rat cardiac allograft survival.
    Oluwole SF; Lau HT; Reemtsma K; Hardy MA
    Transplantation; 1988 Feb; 45(2):293-7. PubMed ID: 3278417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significant prolongation of animal survival by combined therapy of FR167653 and cyclosporine A in rat renal allografts.
    Azuma H; Wada T; Gotoh R; Furuichi K; Sakai N; Yazawa K; Yokoyama H; Katsuoka Y; Takahara S
    Transplantation; 2003 Oct; 76(7):1029-36. PubMed ID: 14557748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selectin inhibitor bimosiamose prolongs survival of kidney allografts by reduction in intragraft production of cytokines and chemokines.
    Langer R; Wang M; Stepkowski SM; Hancock WW; Han R; Li P; Feng L; Kirken RA; Berens KL; Dupre B; Podder H; Dixon RA; Kahan BD
    J Am Soc Nephrol; 2004 Nov; 15(11):2893-901. PubMed ID: 15504942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diminished cytotoxic gene expression in rat cardiac transplants with low-dose cyclosporine/methotrexate combination therapy.
    Pizarro TT; Malinowska K; Kovacs EJ; Clancy J; Robinson JA; Piccinini LA
    Transplantation; 1994 Jul; 58(2):223-32. PubMed ID: 8042241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Both L- and D-isomers of allotrap 2702 prolong cardiac allograft survival in mice.
    Gao L; Woo J; Buelow R
    J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):78-87. PubMed ID: 8820086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conversion from cyclosporine A to mycophenolate mofetil protects recipient kidney and prevents intimal hyperplasia in rat aortic allografts.
    Shimizu H; Takahashi M; Takeda S; Inoue S; Fujishiro J; Hakamata Y; Kaneko T; Murakami T; Takeyoshi I; Morishita Y; Kobayashi E
    Transpl Immunol; 2004 Nov; 13(3):219-27. PubMed ID: 15381205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of chronic allograft nephropathy at late stages using everolimus or FTY720 in combination with cyclosporine.
    Roos M; Liu S; Strobl M; Schmaderer C; Baumann M; Heemann U; Lutz J
    Transplant Proc; 2008 Dec; 40(10):3731-6. PubMed ID: 19100477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunomodulating effects of second-generation calcium channel blockers on experimental heart transplantation.
    Lapointe N; Chen H; Qi S; Xu D; Daloze P; Dumont L
    Eur Surg Res; 1999; 31(3):259-66. PubMed ID: 10352354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.